Lifeboat Foundation

My new Psychology Today story on BREXIT and the EU:

Scientific innovation doesn’t just happen on its own. It takes stable economies, free societies, and open-minded governments. The best environment for science to thrive in is that of collaborating groups incentivized to communicate and cooperate with one another. This is precisely what the European Union is.

And now, more than ever, the union of Europe is needed—because we are crossing over into the transhumanist age, where radical science and technology will engulf our lives and challenge our institutions. Robots will take 75% of the jobs in the next 25 years. CRISPR gene editing technology will allow us to augment our intelligence, perhaps doubling our IQ. Bionic organs will stave off death, allowing 200 year lifespans.

Continue reading “Scientific Innovation Needs the European Union to Succeed” »

(Phys.org)—Inspired by natural selection and the concept of “survival of the fittest,” genetic algorithms are flexible optimization techniques that can find the best solution to a problem by repeatedly selecting for and breeding ever “fitter” generations of solutions.

Now for the first time, researchers Urtzi Las Heras et al. at the University of the Basque Country in Bilbao, Spain, have applied genetic algorithms to digital quantum simulations and shown that genetic algorithms can reduce quantum errors, and may even outperform existing optimization techniques. The research, which is published in a recent issue of Physical Review Letters, was led by Ikerbasque Prof. Enrique Solano and Dr. Mikel Sanz in the QUTIS group.

In general, quantum simulations can provide a clearer picture of the dynamics of systems that are impossible to understand using conventional computers due to their high degree of complexity. Whereas computers calculate the behavior of these systems, quantum simulations approximate or “simulate” the behavior.

Continue reading “Genetic algorithms can improve quantum simulations” »

Excellent!!! Cannot wait until we eradicate cancer, MS, Parkinson, Dystonia, Cystic-Fibrosis, LGD, etc.

A team of Physicians at the University of Pennsylvania’s School of Medicine now has their project of modifying the immune cells of 18 different cancer patients with the CRISPR-Cas9 system approved by the National Institute of Health.

CRISPR is the gift that keeps on giving—when it’s not fighting blindness, tackling HIV, or even recording real-time immune responses, it is taking on the emperor of all maladies: cancer.

Continue reading “Approved: First Ever Human Trials Involving CRISPR Gene Editing” »

Scientists are one step closer to using CRISPR gene editing on humans, with a US federal advisory panel approving the use of the technique for a study led by the University of Pennsylvania.

The scientists are seeking to use the CRISPR-Cas9 technique to create genetically altered T cells – white blood cells that play an important role in our immune system – that are more effective at fighting cancer cells in patients with melanoma, multiple myeloma, and sarcoma.

“Our preliminary data suggests that we could improve the efficacy of these T cells if we use CRISPR,” lead researcher Carl June told the National Institute of Health’s (NIH) Recombinant DNA Advisory Committee (RAC) on Tuesday.

Continue reading “A federal panel just gave the green light to use gene editing on humans” »

Always a trickle down effect on things that improve or change. Just reconfirms and reminds us organically how everything is indeed connected.

Capital tends to have greater value the more skilled and educated the workforce. Anticipating genetically enhanced workers would cause firms to want to invest more now in new equipment and buildings. Many assets, such as real estate and intellectual property, become more valuable the richer a society and so expectations of a much higher economic growth rate would cause companies to spend more buying and developing these assets so that businesses, as well as governments, will wish to borrow more when they realize the potential of human genetic engineering.

Many individuals will reduce their savings rate in anticipation of a future richer society. Today, fear that Social Security won’t survive motivates many Americans to save, but this fear and so this incentive for saving would disappear once genetic engineering for intelligence proves feasible. Furthermore, many citizens would rationally expect future government benefits to senior citizens to increase in a world made richer by genetic engineering and this expectation would reduce the perceived need to save for retirement.

Continue reading “Genetically enhancing our children could raise interest rates” »

I’m 55 years old. I’m shooting for a multihundred-year lifespan. That’s my goal. If you don’t shoot for it, you’re not going to hit it, right?”

I guess he’ll want to speak to George Church.

The author of this titles it “to 150” yet Peter here says multi hundred, and included a pic of Venter who has said he doesn’t think people should live past 120.

Continue reading “How to Live to 150” »

Provided the variants for intelligence can be figured out and the genetic editing tools sufficiently refined (no small matter, in either case), Hsu thinks there’s an incredible potential for improvement. He’s written for the science magazine Nautilus that his calculations from the work at BGI indicate a potential for “very roughly, about 100 standard deviations of improvement, corresponding to an IQ of over 1,000.”

That’s a level of intelligence beyond what we can comprehend right now.

At the same time, we’re not just working on improving biological intelligence. We’re also working on artificial intelligence and machine learning. Smarter humans might be better able to solve those problems, helping us create smarter machines. Smart machines capable of processing big data are already essential for efforts to understand millions of human genomes. These things work together.

Continue reading “We’re about to become more intelligent than at any other point in human history” »

Let’s hope it actually works!

The new goal is to reverse aging, not only in animals, but in humans. And age reversal is essential, as significant age-related disruption has already occurred in most people due to changes in our gene expression profiles.

Gene expression patterns change with age. This influences the rate at which an individual ages, and also determines what senile disorders they are likely to contract. But innovative gene-editing methods based on a unique technology called CRISPR (clustered regularly interspaced short palindromic repeats) are now being successfully harnessed for use as an age-reversal therapy for humans.

In response to these breakthroughs, Life Extension® magazine sent biogerontologist Dr. Gregory M. Fahy to Harvard University to interview Dr. George Church, who is a leading developer of cutting-edge CRISPR techniques. Here, Dr. Church explains remarkable opportunities for transforming human aging that may begin to unfold sooner than most have imagined.

Continue reading “First phase 1 human aging reversal trials (GDF, Myostatin) in a year or two and George Church discusses how to affordably rejuvenate the whole body” »